Neurocrine Biosciences (NBIX) Q4 Earnings and Revenues Lag Estimates

Neurocrine Biosciences (NBIX) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of$ 1.56 per share. This compares to earnings of $1.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -35.90%. A quarter ago, it was expected that this biopharmaceutical company would post earnings of$ 1.47 per share when it actually produced earnings of $1.24, delivering a surprise of -15.65%.Over the last fou ...